Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > who is selling at these prices
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by Skyscraper31on Mar 02, 2018 9:05pm
84 Views
Post# 27655041

RE:RE:RE:RE:who is selling at these prices

RE:RE:RE:RE:who is selling at these pricesNice catch. Buddy is just looking for sympathy I suppose. Wrong forum for that I'm afraid! Anyways, back to business and why I wanted to post: does anyone have a comp to research plausible price point of the capsules? I assume margins will be substantial relative to other products like dried flower...but would they be priced similar to other pharma grade pain opiates...ie oxycontin ;)...or similar to say Tylenol for the end user?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities